Bleichroeder Acquisition Corp. II SEC Filings

Bleichroeder Acquisition 2 France II (File No. 001-43045) distributed a communication highlighting The Wall Street Journal coverage of rising public-market interest in pure-play quantum companies and noting Pasqal among firms planning public listings. The communication discusses the proposed business combination between Bleichroeder and Pasqal and states that a Registration Statement on Form F-4 will be filed; the transaction will be submitted to Bleichroeder shareholders for approval.

The release contains standard forward-looking statements language listing risks such as shareholder redemptions, regulatory approvals, financing needs, and commercialization uncertainty, and directs investors to review the Registration Statement and the forthcoming definitive proxy statement/prospectus when available.

Bleichroeder Acquisition 2 France filed a communication announcing that Pasqal secured a European grant to lead the CoPaNA project. The initiative is a €4 million program over three years, selected under the European Defence Fund, to develop concatenated parity codes on neutral-atom processors with ParityQC and Thales.

The grant is described as defence‑relevant research toward fault‑tolerant, scalable quantum computing; the communication also reiterates customary forward‑looking statement disclosures tied to the pending business combination and upcoming Form F-4 registration process.

Bleichroeder Acquisition 2 France II discusses the growing wave of pure-play quantum computing companies entering public markets and notes Pasqal’s planned business combination with Bleichroeder. The communication describes SPACs as a faster route to public markets and lists multiple quantum firms that recently went public or expect to do so in 2026.

The filing identifies forward-looking statements about the proposed business combination with Pasqal, the plan to file a registration statement on Form F-4, and the requirement for shareholder and regulatory approvals. It directs investors to review the Registration Statement and proxy materials when available.

Bleichroeder Acquisition 2 France II disclosed a proposed business combination with Pasqal Holding SAS, describing how a public listing would support Pasqal's scaling and global ambitions. The communication explains that a Registration Statement on Form F-4 will be filed and that a definitive proxy statement/prospectus will be mailed after the Registration Statement is declared effective.

Bleichroeder Acquisition 2 France II posted a communication describing the proposed business combination with Pasqal Holding SAS and highlighted a Barron’s article on quantum companies going public. The notice states that Bleichroeder intends to file a Form F-4 (registration statement/proxy statement-prospectus) in connection with the shareholder vote and related securities issuances. The communication contains extensive forward-looking statements and a non-exhaustive list of risks tied to consummation, financing, regulatory approvals, shareholder redemptions, commercialization, and operational execution. It reminds readers that the definitive proxy statement/prospectus will be mailed after the Registration Statement is declared effective and directs investors to obtain copies from the SEC.

Bleichroeder Acquisition 2 France II proposes a business combination with Pasqal Holding SAS and intends to file a registration statement on Form F-4 to serve as the proxy statement/prospectus for the vote and the securities to be issued in the transaction.

The communication emphasizes that the combination is subject to shareholder and regulatory approvals and contains extensive forward-looking statements describing risks including redemptions, financing, regulatory approvals, and commercialization challenges; investors are directed to review the forthcoming Registration Statement and definitive proxy/prospectus available at www.sec.gov.

Bleichroeder Acquisition Corp. II and Pasqal Holding SAS disclosed plans for a business combination and capital raise to support Pasqal’s commercialization of neutral-atom quantum computers. The presentation highlights €340M in new funding, planned Nasdaq listing in H2 2026, enterprise QPU deployments, and manufacturing scale-up to expand cloud access and vertical use cases.

The CEO described seven operational high‑qubit QPUs, three more in production, partnerships with cloud and HPC providers, and a roadmap toward fault‑tolerant quantum computing (phase transition toward 2030+).

Bleichroeder Acquisition Corp. II reports that Bleichroeder Sponsor 2 LLC and affiliated reporting persons beneficially hold 9,583,333 Class B Ordinary Shares, representing 25.0% of the company's ordinary shares. These Class B shares are convertible into Class A Ordinary Shares on a one-for-one basis, subject to anti-dilution adjustments as described in the registration statement.

Based on the issuer's Form 10-K, the company had 38,333,333 ordinary shares outstanding as of March 16, 2026 (comprised of 28,750,000 Class A and 9,583,333 Class B). The filing discloses shared voting and dispositive power over the reported Class B shares by the Sponsor, Bleichroeder Manager 2 LLC, Andrew Gundlach, and Michel Combes, and notes 5,000,000 private placement warrants held by the Sponsor exercisable at $11.50 per share not exercisable within 60 days.

Bleichroeder Acquisition 2 France II filed a communication describing Pasqal and IQM's planned U.S. public listings via SPAC mergers to access late-stage capital and prepare for industry consolidation. The filing and accompanying discussion note Europe’s €3bn ScaleUp Europe initiative and a proposed €5bn target to bolster deep tech funding.

The communication discloses forward-looking statements about the proposed business combination with Pasqal, associated risks, the planned Form F-4 registration, and references to past fundraising and potential market consolidation.